Tnfrsf11b Mouse shRNA Lentiviral Particle (Locus ID 18383)

CAT#: TL510977V

Tnfrsf11b - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

Product Images

GFP signal was observed under microscope at 48 hours after transduction of TL510977A virus into HEK293 cells. TL510977A virus was prepared using lenti-shRNA TL510977A and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of TL510977B virus into HEK293 cells. TL510977B virus was prepared using lenti-shRNA TL510977B and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL510977C] virus into HEK293 cells. [TL510977C] virus was prepared using lenti-shRNA [TL510977C] and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL510977D] virus into HEK293 cells. [TL510977D] virus was prepared using lenti-shRNA [TL510977D] and TR30037 packaging kit.

Specifications

Product Data

• Locus ID: 18383
• Synonyms: OCIF; Opg; TR1
• Vector: pGFP-C-shLenti
• Format: Lentiviral particles
• RefSeq: BC049782, NM_008764, NM_008764.1, NM_008764.2, NM_008764.3
• UniProt ID: O08712
• Summary: Acts as decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. May also play a role in preventing arterial calcification. May act as decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis.[UniProtKB/Swiss-Prot Function]
• shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
• Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
  
  For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).